Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
American Journal of Medical Genetics. Part A|June 19, 2025
The Expanding Clinical and Genetic Spectrum of Muscle Glycogen Storage Disease 0, (GSD0B)Sarah Donoghue, Smitha Kumble, Pontus Wasling, et al.European Neurology|October 28, 2019
A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis ExacerbationsGuntis Karelis, Rodica Balasa, Jan L De Bleecker, et al.Journal of Neurology|June 9, 2023
Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancyNolwenn Krief, René Gabriel, Cécile Cauquil, et al.European Journal of Neurology|June 25, 2026
Managing Pompe Disease and Enzyme Replacement Therapy During Pregnancy: Challenges and ConsiderationsMaudy T M Theunissen, Zohra Hayat, Françoise Bouhour, et al.Blood|September 22, 2020
CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapiesMarie Le Cann, Françoise Bouhour, Karine Viala, et al.European Journal of Neurology|April 8, 2024
Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort studyCéline Tard, Françoise Bouhour, Maud Michaud, et al.European Journal of Neurology|July 16, 2026
Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort StudyCéline Tard, Sabrina Sacconi, Nadjib Taouagh, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 19, 2023
Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective studyGuillaume Fargeot, Andoni Echaniz-Laguna, Céline Labeyrie, et al.Neurology|July 7, 2023
Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022Claire Lefeuvre, Marie De Antonio, Francoise Bouhour, et al.European Journal of Neurology|August 7, 2024
Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registryEmilie Retailleau, Claire Lefeuvre, Marie De Antonio, et al.Pageof 4